Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, +251

The Lancet Oncology

First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine +5

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro, +16

Journal of Clinical Oncology

Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study

Xavier García del Muro, Pablo Maroto, Josep Gumà, +9

Journal of Clinical Oncology

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Jorge Aparicio, Pablo Maroto, Xavier García del Muro, +15

Journal of Clinical Oncology

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Jorge Aparicio, Xavier García del Muro, Pablo Maroto, +15

Annals of Oncology

Clinical StageDual PolicySurgical OncologyMedicineImmune Checkpoint Inhibitor +6

Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins

Sandra Guaita‐Esteruelas, Alba Bosquet, Paula Saavedra-García, +6

Molecular Carcinogenesis

Signal TransductionSignaling PathwayBiochemistryLipid SynthesisMedicine +13

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro, +17

Annals of Oncology

Prognostic FactorsRisk-adapted StudiesUrologyMedicineCancer Recurrence +7

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study

Antonio Rueda‐Domínguez, A. Márquez, Josep Gumà, +5

Annals of Oncology

Lymphoid NeoplasiaSurgical OncologyAbvd ChemotherapyMedicineMalignant Blood Disorder +5

Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours

Pablo Maroto, Xavier García del Muro, Jorge Aparicio, +7

Annals of Oncology

Surgical OncologyGenitourinary CancerMulticentre Risk-adapted ManagementMedicineCancer Management +5

Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

Xavier García del Muro, E. Marcuello, Josep Gumà, +7

British Journal of Cancer